ISRG
Price
$533.71
Change
-$0.48 (-0.09%)
Updated
Jun 27 closing price
Capitalization
141.46B
23 days until earnings call
MASI
Price
$168.03
Change
+$1.32 (+0.79%)
Updated
Jun 27 closing price
Capitalization
7.66B
44 days until earnings call
Interact to see
Advertisement

ISRG vs MASI

Header iconISRG vs MASI Comparison
Open Charts ISRG vs MASIBanner chart's image
Intuitive Surgical
Price$533.71
Change-$0.48 (-0.09%)
Volume$2.02M
Capitalization141.46B
Masimo
Price$168.03
Change+$1.32 (+0.79%)
Volume$1.22M
Capitalization7.66B
ISRG vs MASI Comparison Chart in %
Loading...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ISRG vs. MASI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Buy and MASI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ISRG: $533.71 vs. MASI: $168.03)
Brand notoriety: ISRG: Notable vs. MASI: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ISRG: 124% vs. MASI: 186%
Market capitalization -- ISRG: $141.46B vs. MASI: $7.66B
ISRG [@Medical Specialties] is valued at $141.46B. MASI’s [@Medical Specialties] market capitalization is $7.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISRG’s FA Score shows that 1 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • ISRG’s FA Score: 1 green, 4 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than ISRG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISRG’s TA Score shows that 6 TA indicator(s) are bullish while MASI’s TA Score has 8 bullish TA indicator(s).

  • ISRG’s TA Score: 6 bullish, 4 bearish.
  • MASI’s TA Score: 8 bullish, 3 bearish.
According to our system of comparison, MASI is a better buy in the short-term than ISRG.

Price Growth

ISRG (@Medical Specialties) experienced а +4.78% price change this week, while MASI (@Medical Specialties) price change was +1.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Reported Earning Dates

ISRG is expected to report earnings on Jul 22, 2025.

MASI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($141B) has a higher market cap than MASI($7.66B). MASI has higher P/E ratio than ISRG: MASI (95.93) vs ISRG (78.50). ISRG YTD gains are higher at: 2.251 vs. MASI (1.652). ISRG has higher annual earnings (EBITDA): 2.19B vs. MASI (237M). ISRG has more cash in the bank: 5.22B vs. MASI (163M). ISRG has higher revenues than MASI: ISRG (7.12B) vs MASI (2.05B).
ISRGMASIISRG / MASI
Capitalization141B7.66B1,840%
EBITDA2.19B237M924%
Gain YTD2.2511.652136%
P/E Ratio78.5095.9382%
Revenue7.12B2.05B348%
Total Cash5.22B163M3,204%
Total DebtN/A970M-
FUNDAMENTALS RATINGS
ISRG vs MASI: Fundamental Ratings
ISRG
MASI
OUTLOOK RATING
1..100
6078
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
20100
SMR RATING
1..100
5397
PRICE GROWTH RATING
1..100
5248
P/E GROWTH RATING
1..100
5816
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISRG's Valuation (88) in the Medical Specialties industry is in the same range as MASI (90). This means that ISRG’s stock grew similarly to MASI’s over the last 12 months.

ISRG's Profit vs Risk Rating (20) in the Medical Specialties industry is significantly better than the same rating for MASI (100). This means that ISRG’s stock grew significantly faster than MASI’s over the last 12 months.

ISRG's SMR Rating (53) in the Medical Specialties industry is somewhat better than the same rating for MASI (97). This means that ISRG’s stock grew somewhat faster than MASI’s over the last 12 months.

MASI's Price Growth Rating (48) in the Medical Specialties industry is in the same range as ISRG (52). This means that MASI’s stock grew similarly to ISRG’s over the last 12 months.

MASI's P/E Growth Rating (16) in the Medical Specialties industry is somewhat better than the same rating for ISRG (58). This means that MASI’s stock grew somewhat faster than ISRG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ISRGMASI
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 10 days ago
57%
Bearish Trend 4 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
59%
Aroon
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RNP22.630.41
+1.85%
Cohen & Steers REIT and Preferred and Income Fund
QDVO27.490.19
+0.68%
Amplify CWP Growth & Income ETF
TSI4.970.03
+0.61%
TCW Strategic Income Fund
AVIE60.88-0.04
-0.06%
Avantis Inflation Focused Equity ETF
KEMX32.09-0.06
-0.19%
KraneShares MSCI Em Mkts ex CHN ETF

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
-0.09%
BSX - ISRG
73%
Closely correlated
+1.86%
SYK - ISRG
66%
Loosely correlated
+0.81%
NTRA - ISRG
56%
Loosely correlated
-0.12%
MMSI - ISRG
54%
Loosely correlated
+0.75%
GKOS - ISRG
49%
Loosely correlated
+0.36%
More

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with ISRG. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
+0.79%
ISRG - MASI
47%
Loosely correlated
-0.09%
BSX - MASI
44%
Loosely correlated
+1.86%
INSP - MASI
44%
Loosely correlated
+2.08%
VCYT - MASI
43%
Loosely correlated
+2.13%
MMSI - MASI
41%
Loosely correlated
+0.75%
More